ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

231 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

Phase 3Atopic Dermatitis

RuxolitinibVehicle Cream

Incyte Corporation240 participants96 sites · United States, Belgium, CanadaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Phase 1Atopic Dermatitis (AD)

Onabotulinum Toxin Type A - Phase 1bOnabotulinum Toxin Type A - Phase 2

Daniel Kaplan8 participants2 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China

N/ACesarean Delivery

Labor Induction at 39 WeeksExpectant management

Women's Hospital School Of Medicine Zhejiang University1,074 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

N/ADermatitis, AtopicDermatitisEczema

Pfizer200 participants8 sites · TaiwanCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

N/APsoriasis (PsO)Vitiligo VulgarisAtopic Dermatitis

Fondazione Policlinico Universitario Agostino Gemelli IRCCS400 participants1 site · ItalyCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

N/AAtopic Dermatitis EczemaAgingDiet Modification

Nutrient-fortified eggRegular egg with habitual diet

National University of Singapore44 participants1 site · SingaporeCompletes Nov 2025

Compare CT.gov Full analysis →

Recruiting

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

N/AAtopic Dermatitis (AD)AutoantibodyAuto-Immunity

Development of atopic dermatitis with/without IgE autoantibodies

Universitair Ziekenhuis Brussel500 participants1 site · BelgiumCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

N/AAtopic Dermatitis

Swiss Society of Dermatology and Venereology700 participants9 sites · SwitzerlandCompletes May 2032

Compare CT.gov Full analysis →

Recruiting

Prevalence of FGIDs and Probiotics Study

N/AFunctional Gastrointestinal DisordersInfant Conditions

BiogaiaPlacebo

Chulalongkorn University512 participants1 site · ThailandCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Phase 2Atopic DermatitisEczema, Atopic

PF-08049820Placebo

Pfizer165 participants10 sites · United States, JapanCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Phase 2Atopic DermatitisAtopic Dermatitis EczemaEczema

SoquelitinibPlacebo

Corvus Pharmaceuticals, Inc.200 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders: the NILT Study

N/AFood Allergy in Children

Federico II University100 participants1 site · ItalyCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Dupixent and Narrowband UVB for Atopic Dermatitis

Phase 4Atopic Dermatitis

Dupixent

Psoriasis Treatment Center of Central New Jersey40 participants1 site · United StatesCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Phase 2Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis

zabalafin

Alphyn Biologics72 participants12 sites · AustraliaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

1–15 of 231

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

231 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

Phase 3Atopic Dermatitis

RuxolitinibVehicle Cream

Incyte Corporation240 participants96 sites · United States, Belgium, CanadaCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Phase 1Atopic Dermatitis (AD)

Onabotulinum Toxin Type A - Phase 1bOnabotulinum Toxin Type A - Phase 2

Daniel Kaplan8 participants2 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China

N/ACesarean Delivery

Labor Induction at 39 WeeksExpectant management

Women's Hospital School Of Medicine Zhejiang University1,074 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

N/ADermatitis, AtopicDermatitisEczema

Pfizer200 participants8 sites · TaiwanCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

N/APsoriasis (PsO)Vitiligo VulgarisAtopic Dermatitis

Fondazione Policlinico Universitario Agostino Gemelli IRCCS400 participants1 site · ItalyCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

N/AAtopic Dermatitis EczemaAgingDiet Modification

Nutrient-fortified eggRegular egg with habitual diet

National University of Singapore44 participants1 site · SingaporeCompletes Nov 2025

Compare CT.gov Full analysis →

Recruiting

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

N/AAtopic Dermatitis (AD)AutoantibodyAuto-Immunity

Development of atopic dermatitis with/without IgE autoantibodies

Universitair Ziekenhuis Brussel500 participants1 site · BelgiumCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

N/AAtopic Dermatitis

Swiss Society of Dermatology and Venereology700 participants9 sites · SwitzerlandCompletes May 2032

Compare CT.gov Full analysis →

Recruiting

Prevalence of FGIDs and Probiotics Study

N/AFunctional Gastrointestinal DisordersInfant Conditions

BiogaiaPlacebo

Chulalongkorn University512 participants1 site · ThailandCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Phase 2Atopic DermatitisEczema, Atopic

PF-08049820Placebo

Pfizer165 participants10 sites · United States, JapanCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Phase 2Atopic DermatitisAtopic Dermatitis EczemaEczema

SoquelitinibPlacebo

Corvus Pharmaceuticals, Inc.200 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders: the NILT Study

N/AFood Allergy in Children

Federico II University100 participants1 site · ItalyCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Dupixent and Narrowband UVB for Atopic Dermatitis

Phase 4Atopic Dermatitis

Dupixent

Psoriasis Treatment Center of Central New Jersey40 participants1 site · United StatesCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Phase 2Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis

zabalafin

Alphyn Biologics72 participants12 sites · AustraliaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

1–15 of 231